Laura Dima, MD

Bayer HealthCare SAS, Medical Affairs
La Garenne-Colombes, Ile-de-France, France

Presentation(s):

• Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL

  Thursday, November 17, 2022
  2:16 PM – 2:24 PM